NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ:ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged […]

NEW YORK, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against CTO Realty Growth, Inc. ("CTO" or the "Company") (NYSE:CTO) and certain officers. The class action, filed in the United States District Court for the Middle District of Florida, and docketed under 25-cv-01516,

NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of GSK plc ("GSK" or the "Company") (NYSE:GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GSK and certain of its officers and/or directors

SINGAPORE, Aug. 30, 2025 (GLOBE NEWSWIRE) — With the return of the bull market and Bitcoin reaching new all-time highs, BexBack is helping traders quickly build wealth by offering 100x leverage and a double deposit bonus, with no KYC required. This initiative ensures that every trader can take advantage of the wealth-building potential provided by

NEW YORK, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ:RARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ultragenyx and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. ("Simulations Plus" or the "Company") (NASDAQ:SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Simulations Plus and certain of its

NEW YORK, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Necessity Retail REIT, Inc. ("Necessity Retail" or the "Company") (NASDAQ:RTL) who received shares of Global Net Lease, Inc. ("Global Net Lease") in connection with Global Net Lease’s acquisition of Necessity Retail on September 12,

NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE:EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Encompass and certain of its officers and/or

NEW YORK, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Geely Automobile Holdings Limited ("Geely" or the "Company") (OTCMKTS:GELYF; GELYY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Geely and certain of its officers

NEW YORK CITY, NY / ACCESS Newswire / August 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Barnes & Noble Education, Inc. ("Barnes & Noble" or the "Company") (NYSE:BNED). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Barnes & Noble